InflaRx NV
NASDAQ:IFRX
InflaRx NV
Selling, General & Administrative
InflaRx NV
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
InflaRx NV
NASDAQ:IFRX
|
Selling, General & Administrative
-€18.1m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Selling, General & Administrative
-€551.7m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-83%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Selling, General & Administrative
-€323.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-33%
|
|
CureVac NV
NASDAQ:CVAC
|
Selling, General & Administrative
-€81.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Selling, General & Administrative
-€37.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Selling, General & Administrative
-€104.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
See Also
What is InflaRx NV's Selling, General & Administrative?
Selling, General & Administrative
-18.1m
EUR
Based on the financial report for Mar 31, 2024, InflaRx NV's Selling, General & Administrative amounts to -18.1m EUR.
What is InflaRx NV's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-7%
Over the last year, the Selling, General & Administrative growth was -28%. The average annual Selling, General & Administrative growth rates for InflaRx NV have been -26% over the past three years , -7% over the past five years .